Victoza

Victoza (liraglutide) is a prescription medication used to treat Type 2 diabetes. A once-daily injectable for adults and children with type 2 diabetes to improve blood sugar, also shown to reduce cardiovascular risk in adults.

A GLP-1 receptor agonist that prompts the body to release insulin when blood sugar is high and slows digestion.

Commonly reported side effects of Victoza include Nausea, Diarrhea, Headache, Risk of thyroid C-cell tumors (boxed warning), and Low blood sugar with other diabetes drugs. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Victoza carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Victoza is liraglutide, which belongs to a class of medicines known as GLP-1 Receptor Agonist.

Victoza is manufactured by Novo Nordisk. It was first approved in 2010.

You may be able to lower the cost of Victoza by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.